MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-RJ-02-0003672
Gracure Pharmaceuticals Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹287.44 Cr
▲ 27% YoY
Net profit · FY 2025
₹35.1 Cr
Net margin 12.2%
EBITDA · FY 2025
₹54.74 Cr
EBITDA margin 19%
Authorised capital
₹5.25 Cr
Registered with MCA
Paid-up capital
₹2.82 Cr
Issued & subscribed
Open charges
₹20.88 Cr
Satisfied ₹18.45 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
529
Provident fund records
About Gracure Pharmaceuticals Limited
Data last updated:
Gracure Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL1992PLC049002. Its GSTIN is 08AAACG1814F1Z2 (Rajasthan). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5.25 Cr and a paid-up capital of ₹2.82 Cr. It is led by directors including Amreshwar Sahai Bhargava (Managing Director) and Sudhir Bhargava (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 251 – 254 Iind Floor DLF Tower 15 Shivaji Marg, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹287.44 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹35.1 Cr (net margin 12.2%) and EBITDA of ₹54.74 Cr (EBITDA margin 19%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 17% over five years.
The company has about 529 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Gracure. As per MCA filings, the company has open charges of ₹20.88 Cr and satisfied charges of ₹18.45 Cr on record. Court records list 26 cases involving the company, including 10 filed by the company and 16 filed against it; 3 cases are pending. The company has 4 deals on record (4 secondary share transfers); the latest was in March 2024. Its 6 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Globela Pharma Private Limited with revenue of ₹295.59 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2023, listing 523 overdue payments to 63 micro and small suppliers.
Gracure Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-02-0003672). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gracure.com.
Company details
CIN U24232DL1992PLC049002
Registration Number 049002
Incorporation Date 01 June 1992
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-RJ-02-0003672
Key People
Amreshwar Sahai Bhargava Managing Director Sudhir Bhargava Whole-Time Director Parag Bhargava Whole-Time Director Recognitions & Rankings of Gracure Pharmaceuticals
Contact details
Gracure Pharmaceuticals Limited's registered office is in New Delhi, Delhi. Its website is gracure.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address251 – 254 Iind Floor DLF Tower 15 Shivaji Marg, New Delhi, Delhi, India – 110015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gracure Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Gracure Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Gracure Pharmaceuticals operates one associated brand: Gracure. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, R&D, and regulatory services with global reach. | gracure.com |
Business activity
The main business activity of Gracure Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gracure Pharmaceuticals Limited, buy the company report.
Financials of Gracure Pharmaceuticals Limited
FY 2025 filings availableGracure Pharmaceuticals Limited reported revenue of ₹287.44 Cr (up 27% YoY) for FY 2025.
Revenue · FY 2025
₹287.44 Cr ▲ 27%
Net profit · FY 2025
₹35.1 Cr margin 12.2%
EBITDA · FY 2025
₹54.74 Cr margin 19%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 9%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 3%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 27% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹54.74 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19% | ||||
| Net Profit Margin | 12.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gracure Pharmaceuticals Limited, buy the company report.
Board of directors of Gracure Pharmaceuticals Limited
Gracure Pharmaceuticals has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Bhargava | Whole-Time Director | 27 Nov 2001 | 24 Years 11 Months | Current |
| Parag Bhargava | Whole-Time Director | 10 Aug 2002 | 24 Years 2 Months | Current |
| Amreshwar Sahai Bhargava | Managing Director | 25 Nov 1992 | 33 Years 11 Months | Current |
| Harshad Vaid Also directs: Uni Agencies Chemicals Private Ltd | Director | 05 May 1995 | 31 Years 5 Months | Current |
| Pradeep Kumar Rastogi Also directs: Jaypi Virtus LLP | Whole-Time Director | 13 Mar 2002 | 24 Years 7 Months | Current |
Peer comparison
Gracure Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Globela Pharma Private Limited | ₹295.59 Cr (FY 2025) | 13.0% | Surat, Gujarat, India | |||
| Ravenbhel Health Care Private Limited | ₹290.95 Cr (FY 2025) | 16.0% | Jammu, Jammu and Kashmir, India | |||
| Agio Pharmaceuticals Limited | ₹287.95 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India | |||
| Gracure Pharmaceuticals Limitedthis company | ₹287.44 Cr (FY 2025) | ₹35.1 Cr | 12.2% | 27.0% | 529 | New Delhi, Delhi, India |
| Pinnacle Life Science Private Limited | ₹286.72 Cr (FY 2023) | -2.0% | Baddi, Himachal Pradesh, India | |||
| Sava Healthcare Limited | ₹284.97 Cr (FY 2025) | 14.0% | Wadhwan, Gujarat, India | |||
| Med Manor Organics Private Limited | ₹284.93 Cr (FY 2025) | 5.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Gracure Pharmaceuticals Limited, buy the company report.
Auditor
Gracure Pharmaceuticals Limited is audited by Dadu Dadoo & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Dadu Dadoo & Associates | FY 2024 | 006760N |
Shareholding
The shareholding of Gracure Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Gracure Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹20.88 Cr
Satisfied charges
₹18.45 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2025 | 101155676 | Axis Bank Limited | ₹10 Cr | Open | |
| 25 Oct 2024 | 101022120 | Others | ₹1.4 Cr | Open | |
| 07 Oct 2022 | 100622109 | Axis Bank Limited | ₹95 Lakh | Open | |
| 13 Sep 2021 | 100495489 | Hdfc Bank Limited | ₹11.2 Lakh | Open | |
| 10 Jun 2021 | 100456670 | Hdfc Bank Limited | ₹50 Lakh | Open |
To see the full charge records of Gracure Pharmaceuticals Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Gracure Pharmaceuticals Limited has 4 deals on record (4 secondary share transfers); the latest was in March 2024.
Total deals
4
Secondary share transfers
4
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Gracure Pharmaceuticals Limited has 26 court cases on record: 10 filed by Gracure Pharmaceuticals, 16 filed against it. 3 cases are pending and 23 are disposed.
Total cases
26
Filed by the company
10
Filed against the company
16
Pending
3
Disposed
23
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 16 | 11 | 2 |
| District courts | 8 | 3 | 1 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Allahabad High Court | Court case (A227) | Filed against the company by Jamp India Pharmaceuticals Private Limited | Disposed |
| Allahabad High Court | Court case (A227) | Filed against the company by Medreich Limited | Disposed |
| Allahabad High Court | Court case (A227) | Filed by the company against Medreich Limited and 3 others | Disposed |
| High Court, UTTARPRADESH | Court case (COPL) | Filed against the company by V S International Private Limited | Disposed |
| High Court, UTTARPRADESH | Court case (FAFOD) | Filed against the company by Jamp India Pharmaceuticals Private Limited | Disposed |
To see the full case history of Gracure Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Gracure Pharmaceuticals Limited has 11 MSME Form 1 returns on record between 2019 and 2023, listing 523 overdue payments to 63 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 63)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| S S Data Code India Private Limited | |||
| K.L. Datta & Co. | |||
| an individual supplier | |||
| an individual supplier | |||
| Indo Printographic Private Limited |
To see the full MSME payment records of Gracure Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Gracure Pharmaceuticals Limited has a workforce of 529 employees on its EPFO records as of Aug 28, 2025, across 3 active EPFO establishments.
Employee count
529
Active EPFO establishments
3
Employee growth
13.76%
GST
Gracure Pharmaceuticals has 4 GST registrations: 1 active and 3 cancelled or inactive.
Total GSTINs
4
Active
1
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAACG1814F1Z2 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gracure Pharmaceuticals Limited, buy the company report.
Recent activity
Gracure Pharmaceuticals Limited has 6 board changes on record since 1992: 5 appointments and 1 cessation. The latest: Chandreshwar Sahai Bhargava ceased to be Director on 05 Jun 2019.
AGM
Gracure Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 10.00 Cr with Charge ID 101155676 was registered on 27 Jun 2025.
Filing
Gracure Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 1.40 Cr with Charge ID 101022120 was registered on 25 Oct 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.95 Cr with Charge ID 100622109 was registered on 07 Oct 2022.
Charges
A charge with Others of Rs. 7.50 Cr registered on 26 Aug 2003 with Charge ID 90062917 was modified on 14 Sep 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.11 Cr with Charge ID 100495489 was registered on 13 Sep 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.50 Cr with Charge ID 100456670 was registered on 10 Jun 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.06 Cr with Charge ID 100440975 was registered on 08 Mar 2021.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.36 Cr with Charge ID 100330340 was registered on 27 Dec 2019.
Ceased
Chandreshwar Sahai Bhargava ceased to be Director.
Charges
A charge registered on 26 Mar 2008 via Charge ID 10107953 with Icici Bank Limited was fully satisfied on 26 Jul 2013.
15 earlier events are in the company report.
Frequently asked questions
Gracure Pharmaceuticals is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 June 1992 (34+ years old) and is registered under CIN U24232DL1992PLC049002.
Gracure Pharmaceuticals has 5 current directors:
- Amreshwar Sahai Bhargava - Managing Director
- Sudhir Bhargava - Whole-Time Director
- Parag Bhargava - Whole-Time Director
- Pradeep Kumar Rastogi - Whole-Time Director
- Harshad Vaid - Director
The latest financial statements of Gracure Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gracure Pharmaceuticals is 08AAACG1814F1Z2, registered in Rajasthan. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of Gracure Pharmaceuticals is U24232DL1992PLC049002. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gracure Pharmaceuticals has 26 court cases on record: 10 filed by the company and 16 filed against it. 3 are pending. Most are in the high courts.
Gracure Pharmaceuticals was incorporated on 01 June 1992, making it 34+ years old. It is registered with the Registrar of Companies, Delhi.
Gracure Pharmaceuticals has 4 deals on record (4 secondary share transfers); the latest was in March 2024.
The peers of Gracure Pharmaceuticals by revenue are Globela Pharma Private Limited, Ravenbhel Health Care Private Limited, Agio Pharmaceuticals Limited, Pinnacle Life Science Private Limited, Sava Healthcare Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandreshwar Sahai Bhargava ceased to be Director on 05 Jun 2019. Parag Bhargava was appointed as Whole-Time Director on 10 Aug 2002. Pradeep Kumar Rastogi was appointed as Whole-Time Director on 13 Mar 2002. Gracure Pharmaceuticals has 6 board changes on record in total.
Yes, Gracure Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-RJ-02-0003672).
Gracure Pharmaceuticals has 11 MSME Form 1 returns on record between 2019 and 2023, listing 523 overdue payments to 63 micro and small suppliers. The latest return was filed on 30 Aug 2023.